These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16733232)

  • 1. Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study.
    Palmieri V; Devereux RB; Hollywood J; Bella JN; Liu JE; Lee ET; Best LG; Howard BV; Roman MJ
    Am J Hypertens; 2006 Jun; 19(6):601-7. PubMed ID: 16733232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations of pulse pressure and other components of blood pressure to preclinical echocardiographic abnormalities.
    Celentano A; Palmieri V; Di Palma Esposito N; Pietropaolo I; Arezzi E; Mureddu GF; de Simone G
    J Hypertens; 2002 Mar; 20(3):531-7. PubMed ID: 11875322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction.
    Quiñones MA; Greenberg BH; Kopelen HA; Koilpillai C; Limacher MC; Shindler DM; Shelton BJ; Weiner DH
    J Am Coll Cardiol; 2000 Apr; 35(5):1237-44. PubMed ID: 10758966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
    Palmieri V; Wachtell K; Bella JN; Gerdts E; Papademetriou V; Nieminen MS; Dahlöf B; Roman MJ; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):423-30. PubMed ID: 15002006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of midwall systolic function in left ventricular hypertrophy: a comparison of 3-dimensional versus 2-dimensional echocardiographic indices.
    Jung HO; Sheehan FH; Bolson EL; Waiss MP; Otto CM
    J Am Soc Echocardiogr; 2006 Jun; 19(6):802-10. PubMed ID: 16762760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study.
    Palmieri V; Celentano A; Roman MJ; de Simone G; Lewis MR; Best L; Lee ET; Robbins DC; Howard BV; Devereux RB
    Hypertension; 2001 Nov; 38(5):1068-74. PubMed ID: 11711499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LV mass index significantly impacts on patient and renal outcomes in patients with coronary artery bypass grafting and poor left-ventricular function.
    Lin CL; Hsu PY; Yang CT; Yang HY; Yang TY; Huang WH; Huang CC
    Ren Fail; 2003 Mar; 25(2):287-95. PubMed ID: 12739835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and cardiovascular mortality in dialysis patients with left ventricular systolic dysfunction.
    Losito A; Del Vecchio L; Del Rosso G; Malandra R;
    Am J Hypertens; 2014 Mar; 27(3):401-8. PubMed ID: 24108864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Cicala S; de Simone G; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2008 Apr; 26(4):806-12. PubMed ID: 18327092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Li ZB; Wachtell K; Okin PM; Gerdts E; Liu JE; Nieminen MS; Jern S; Dahlöf B; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):397-402. PubMed ID: 15071485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study.
    Okin PM; Roman MJ; Lee ET; Galloway JM; Howard BV; Devereux RB
    Hypertension; 2004 Apr; 43(4):769-74. PubMed ID: 14769809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension.
    de Simone G; Roman MJ; Koren MJ; Mensah GA; Ganau A; Devereux RB
    Hypertension; 1999 Mar; 33(3):800-5. PubMed ID: 10082490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study.
    Palmieri V; Bella JN; Roman MJ; Gerdts E; Papademetriou V; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2003 Apr; 21(4):781-7. PubMed ID: 12658025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).
    Turakhia MP; Schiller NB; Whooley MA
    Am J Cardiol; 2008 Nov; 102(9):1131-5. PubMed ID: 18940278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.